EDCTP stands for „European and Developing Countries Clinical Trials Partnership“, a research initiative run jointly by European and African countries. Since its foundation in 2003, EDCTP has specifically committed itself to poverty-related, neglected infectious diseases. Given that they affect the poorest regions of Africa, HIV/AIDS, malaria and tuberculosis occupy center stage. Hereby, the main foci of EDCTP are the promotion of clinical trials in order to transfer new vaccines, medicines and diagnostics into clinical practice, as well as to sustainably build and strengthen capacity for clinical trials in Africa, connecting European researchers and African partners.
In total, the European Commission, its member states, foundations and the African partner countries, are investing approximately 2 billion Euros over a period of 20 years in order to improve the health of Africa’s population as well as other countries across the globe.
EDCTP projects are funded by the European Commission, member states, and third parties in accordance with article 185 of the Lisbon Treaty. Public announcements and the selection of the projects are made by the EDCTP secretariat in The Hague, Netherlands. The enlisted German research projects are mostly sub-projects of larger European-African consortia.
